These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31648633)

  • 1. High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal Cancer.
    Du G; Zhou J; Cheng L; Ma X; Gui Y; Tan B
    Comb Chem High Throughput Screen; 2019; 22(9):599-611. PubMed ID: 31648633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-139-5p regulates VEGFR and downstream signaling pathways to inhibit the development of esophageal cancer.
    Jiao W; Zhang J; Wei Y; Feng J; Ma M; Zhao H; Wang L; Jiao W
    Dig Liver Dis; 2019 Jan; 51(1):149-156. PubMed ID: 30245290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-493 by regulating of c-Jun targets Wnt5a/PD-L1-inducing esophageal cancer cell development.
    Bian W; Li Y; Zhu H; Gao S; Niu R; Wang C; Zhang H; Qin X; Li S
    Thorac Cancer; 2021 May; 12(10):1579-1588. PubMed ID: 33793074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
    Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
    PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
    Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
    BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated miR-483-5p expression as a prognostic biomarker for esophageal squamous cell carcinoma.
    Xue L; Nan J; Dong L; Zhang C; Li H; Na R; He H; Wang Y
    Cancer Biomark; 2017; 19(2):193-197. PubMed ID: 28211800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive multi-omics analysis identified core molecular processes in esophageal cancer and revealed GNGT2 as a potential prognostic marker.
    Liu GM; Ji X; Lu TC; Duan LW; Jia WY; Liu Y; Sun ML; Luo YG
    World J Gastroenterol; 2019 Dec; 25(48):6890-6901. PubMed ID: 31908393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
    Luo HS; Wu DH
    Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma.
    Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C
    Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer.
    Zhao JY; Wang F; Li Y; Zhang XB; Yang L; Wang W; Xu H; Liu DZ; Zhang LY
    Med Sci Monit; 2015 Oct; 21():3222-30. PubMed ID: 26498375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-550a is associated with muscle system conferring poorer survival for esophageal cancer.
    Hong H; Liu T; Wu H; Zhang J; Shi X; Le X; Chen AM; Mo H; Huang Q; Zhou H; Rao X
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 31028132
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
    Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
    Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
    Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
    Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microRNAs as prognostic biomarkers for survival in esophageal cancer: a meta-analysis.
    Fu W; Pang L; Chen Y; Yang L; Zhu J; Wei Y
    ScientificWorldJournal; 2014; 2014():523979. PubMed ID: 25097879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
    Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
    Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.